Vesiculobullous eruption with loncastuximab tesirine in a patient with relapsed follicular lymphoma

Previous article in issue Next article in issue Key words dermatologic toxicity follicular lymphoma interface dermatitis loncastuximab tesirine oncologic dermatology vesiculobullous dermatitis Abbreviations used ADC antibody-drug complex CD cluster of differentiation LT loncastuximab tesirine …

Vesiculobullous eruption with loncastuximab tesirine in a patient with relapsed follicular lymphoma Read More